Close

Biocept (BIOC), Insight Genetics Collaborate to Advance Non-Small Cell Lung Cancer Diagnosis

January 8, 2015 8:40 AM EST Send to a Friend
Biocept, Inc. (Nasdaq: BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (ctDNA) and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login